Ignite Creation Date:
2024-05-06 @ 10:16 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03209414
Status:
RECRUITING
Last Update Posted:
2023-04-12
First Post:
2017-06-24
Brief Title:
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Sponsor:
Medical University of Silesia
Organization:
Medical University of Silesia
Study Overview
Official Title:
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Status:
RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FRAPICA
Brief Summary:
The impact of frailty on immediate and long term outcomes of invasive treatment of coronary artery disease is not fully characterized The assessment of frailty may help physicians in the selection of best treatment option and in the timing and modality of the follow-up The FRAilty syndrome in daily Practice of Interventional CArdiology ward FRAPICA study is designed with the aim to validate the use of the Fried frailty scale and instrumental activities of daily living scale IADL as prognostic tools in patients admitted to hospital for symptomatic coronary artery disease either stable unstable or acute coronary syndrome ACS
The FRAPICA study is a single center prospective study enrolling patients aged 65 years The aims are 1 to describe Fried frailty scale and IADL scale distribution before hospital discharge and 2 to investigate the prognostic role of Fried frailty and IADL scores The outcomes are 1 results of invasive treatment 2 its complications periinterventional MI contrast-induced nephropathy blood loss 3 three-year all-cause mortality cardiovascular mortality stroke myocardial infarction reintervention heart failure hospital readmission for any cause and a composite of the above mentioned Ancillary analyses will be focused on different clinical presentations different tools to assess frailty and risk stratification
The FRAPICA program will fill critical gaps in the understanding of the relation between frailty cardiovascular disease interventional procedures and outcome It will enable more personalized risk assessment and identification of new targets for interventions
The FRAPICA study is a single center prospective study enrolling patients aged 65 years The aims are 1 to describe Fried frailty scale and IADL scale distribution before hospital discharge and 2 to investigate the prognostic role of Fried frailty and IADL scores The outcomes are 1 results of invasive treatment 2 its complications periinterventional MI contrast-induced nephropathy blood loss 3 three-year all-cause mortality cardiovascular mortality stroke myocardial infarction reintervention heart failure hospital readmission for any cause and a composite of the above mentioned Ancillary analyses will be focused on different clinical presentations different tools to assess frailty and risk stratification
The FRAPICA program will fill critical gaps in the understanding of the relation between frailty cardiovascular disease interventional procedures and outcome It will enable more personalized risk assessment and identification of new targets for interventions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None